Abstract:Sustained stress leads to series of changes in the brain, firstly through the activation of hypothalamus–pituitary–adrenal (HPA) axis and sympathetic nervous system (SNS) axis, then the release of glucocorticoid (GCs) and catecholamines (CAs), respectively. The circulating GCs can cause neuronal injury and even the loss of neurons, accompanying the increased level of proinflammatory cytokines in the circulation. Chronic stress has been linked to various diseases, especially mood disorders and neuropsychiatric disorders, mainly mediated by the limbic system. Yet the relationship between chronic stress and neurodegenerative disorders such as Alzheimer disease (AD) and Parkinson’s disease (PD) is unknown. It has been found that depression often precedes PD symptoms in clinical subjects [1], while many PD patients present with depression symptoms as well [2,3]. A recent study published in Molecular Psychiatry by Hemmerle et al. [4] addressed this point by subjecting 6-OHDA-lesioned rats to the chronic stress, and they found that chronic stress exacerbates the loss of dopamine neurons induced by 6-OHDA injection. The results strongly argued that chronic stress may function as an important factor in the development of PD and potentially other neurodegenerative diseases. Hemmerle et al. generated a rat model of PD by unilateral 6-OHDA injection, which produces selective toxicity to dopamine neurons, especially in substantia nigra. The dopamine neuron loss leads to motor behavior deficits, as reflected by the forelimb asymmetry test, because the loss of dopamine neurons would lead to impaired usage of the contralateral limb, while the severity of dopamine neuron loss was histologically examined by TH staining [4]. When the rats were subjected to chronic unpredictable stress, the authors found that the rats would demonstrate increased forelimb asymmetry (suggestive of worse behavior), which correlated with increased dopamine neuron loss (decreased TH staining). Interestingly, the chronic stress alone did not induce loss of dopamine neurons, and the stress had to occur simultaneously with toxin exposure [4], suggesting that the stress might act adjuvantly with the toxin or increase the vulnerability of the neurons. In clinical studies, depression as the most common disease caused by chronic stress may occur prior to PD symptoms [1] and may indicate worse prognosis for PD patients [5]. Yet it should be noted that the loss of dopamine neurons could occur much earlier to the motor symptoms [6] and therefore may be concurrent with the depression as well. What are the potential mechanisms linking stress and increased dopamine neuron loss? It is possible that glucocorticoid contributes to this process, partly through the glucocorticoid receptors (GRs) on the microglia, because MPTP-induced neurotoxicity was less in mice whose GRs were knocked down selectively on microglial cells [7]. In addition, GRs on dopamine neurons regulate the activity of the cells and might sensitize the neurons through excitotoxicity [8]. On the other hand, there is evidence suggesting that the depression can be caused by loss of dopaminergic innervation during PD progression [2], acting as the downstream of PD pathology. It is believed that the mesolimbic and mesocortical dopaminergic pathways that are disrupted in PD would contribute to the depression symptoms [3]. Indeed, a recent study has shown that selective activation of midbrain dopamine neurons with optogenetic tech-

Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice

Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice

Chronic Stress and Parkinson's Disease

Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.

Ginsenoside Rg1 ameliorates stress-exacerbated Parkinson's disease in mice by eliminating RTP801 and α-synuclein autophagic degradation obstacle

The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease

Chronic Social and Psychological Stress Impact Select Neuropathologies in the PS19 Mouse Model of Tauopathy

Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease

Lifelong Chronic Psychosocial Stress Induces a Proteomic Signature of Alzheimer's Disease in Wildtype Mice.

The Effects of Stress on Lewy Pathology in Dopamine Neurons

Genomic DNA Levels of Mutant Alpha-Synuclein Correlate with Non-Motor Symptoms in an A53T Parkinson's Disease Mouse Model

Membrane phospholipid peroxidation promotes loss of dopaminergic neurons in psychological stress‐induced Parkinson's disease susceptibility

Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology

Chronic stress induces insulin resistance and enhances cognitive impairment in AD

Non-Motor Parkinsonian Pathology In Aging A53t Alpha-Synuclein Mice Is Associated With Progressive Synucleinopathy And Altered Enzymatic Function

Stress-induced precocious aging in PD-patient iPSC-derived NSCs may underlie the pathophysiology of Parkinson's disease

Chronic mild stress in mice promotes cognitive impairment and CDK5-dependent tau hyperphosphorylation

Effects of Chronic Stress on Cognition in Male Samp8 Mice

Chronic Stress Aggravates Cognitive Impairment and Suppresses Insulin Associated Signaling Pathway in APP/PS1 Mice.

3xTgAD mice exhibit altered behavior and elevated Aβ after chronic mild social stress

The Aggregation of α-Synuclein in the Dorsomedial Striatum Significantly Impairs Cognitive Flexibility in Parkinson's Disease Mice